Picture of Agile Therapeutics logo

AGRX — Agile Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Agile Therapeutics Reports Q2 Loss Per Share Of $0.12

Aug 11 (Reuters) - Agile Therapeutics Inc  AGRX.O :
    * AGILE THERAPEUTICS REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS
    * Q2 LOSS PER SHARE $0.12
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.14 -- REFINITIV IBES
DATA
    * BELIEVE CO IS ON TRACK TO LAUNCH TWIRLA IN Q4 OF 2020
    * SEES Q4 REVENUE IN RANGE OF $1 MILLION TO $2 MILLION

Source text for Eikon:  ID:nGNX7CFrxg 
Further company coverage:  AGRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Agile Therapeutics

See all news